Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation TCT 2014

Covered Stents for Iliac and SFA Obstructive Disease: Overhyped or Underused?

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon

September 13, 2014

Presentation TCT 2013

TCT-133. The Multilayer Flow Modulator Stent for the Treatment of Peripheral and Visceral Aneuryms

Presenter: Michel Henry

October 27, 2013

Presentation TCT 2013

Emerging Experience with the Multilayer Stent

Presenter: Hugo Londero

October 27, 2013

Presentation TCT 2013

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

Presenter: Thomas Zeller

October 27, 2013

Presentation TCT 2013

SFA Stents Can No Longer Be Justified on an Outcomes or Cost Basis!

Presenter: Thomas Zeller

October 27, 2013

Presentation TCT 2013

EPIC Nitinol Stent Treatment of Iliac Artery Lesions: 12-Month Outcomes in the ORION Study

Presenter: Daniel Clair, Julie Adams, Bernard Reen, Robert Feldman, Jean Starr, Juan Diaz-Cartelle, Keith Dawkins

January 31, 2013

Presentation TCT 2013

Clinical and angiographic outcome about External iliac artery(EIA)- internal iliac artery (IIA) bifurcation lesion which jailed IIA comparison between crossover stenting strateg...

Presenter: Takuro Takama, Toshiya Muramatsu, Reiko Tsukahara

January 31, 2013

Presentation TCT 2012

Balloon-Expandable vs. Self-Expanding vs. Covered Stents In Iliac Arteries: Insights from Clinical Trials and Clinical Practice

Presenter: Tony Das

October 23, 2012

Presentation TCT 2012

Final 12 Month Outcomes from the SUPERB Trial Using the Supera Woven Nitinol Stent

Presenter: Lawrence Garcia

October 22, 2012

Presentation TCT 2012

Final Data on the ICARUS Trial of Covered Stents for Obstructive Iliac Disease

Presenter: John Laird Jr

October 22, 2012

Presentation TCT 2012

A Modern Algorithm for Non-Invasive Testing Following Lower Extremity Vascular Stenting

Presenter: Michael Jaff

October 22, 2012

Presentation TCT 2012

Pharmacokinetic Evaluation of Drug Eluting Stents in a Healthy and Atherosclerotic Rabbit Iliac Model

Presenter: Alexander Sheehy, Saami K. Yazdani, Ed Berger, Rosy S. Donn, Tu D. Ngo, Stephen Pacetti, Syed Hossainy, Frank D. Kolodgie, Renu Virmani

January 03, 2012

Presentation TCT 2012

Evaluation of Drug Tissue Concentration Following Stenting in a Healthy Rabbit Iliac Model

Presenter: Alexander Sheehy, Saami K. Yazdani, Ed Berger, Rosy S. Donn, Tu D. Ngo, Stephen Pacetti, Syed Hossainy, Frank D. Kolodgie, Renu Virmani

January 03, 2012

Advertisement

Covered Stents for Iliac and SFA Obstructive Disease: Overhyped or Underused?

TCT-133. The Multilayer Flow Modulator Stent for the Treatment of Peripheral and Visceral Aneuryms

Emerging Experience with the Multilayer Stent

Drug-Coated Balloons in the Management of SFA In-Stent Restenosis: The FAIR Randomized Trial

SFA Stents Can No Longer Be Justified on an Outcomes or Cost Basis!

EPIC Nitinol Stent Treatment of Iliac Artery Lesions: 12-Month Outcomes in the ORION Study

Clinical and angiographic outcome about External iliac artery(EIA)- internal iliac artery (IIA) bifurcation lesion which jailed IIA comparison between crossover stenting strateg...

Balloon-Expandable vs. Self-Expanding vs. Covered Stents In Iliac Arteries: Insights from Clinical Trials and Clinical Practice

Final 12 Month Outcomes from the SUPERB Trial Using the Supera Woven Nitinol Stent

Final Data on the ICARUS Trial of Covered Stents for Obstructive Iliac Disease

A Modern Algorithm for Non-Invasive Testing Following Lower Extremity Vascular Stenting

Pharmacokinetic Evaluation of Drug Eluting Stents in a Healthy and Atherosclerotic Rabbit Iliac Model

Evaluation of Drug Tissue Concentration Following Stenting in a Healthy Rabbit Iliac Model

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content